Bringing Real World Data to Clinical Studies: Q&A With Dr. David Cosgrove of Compass Oncology

Published March 18, 2024

Dr. David Cosgrove, a medical oncologist with Compass Oncology, presented the results of a study on the first-line use of atezolizumab plus bevacizumab on patients with a certain type of liver cancer at ASCO GI earlier this year. He recently spoke with Pharmaceutical Executive about some of the methods used in the study to bring real-world data into the fold. Read the article